Sign in

CIK 0001034842

  • Accelerated filer

RIGEL PHARMACEUTICALS INC

Sign in to watch
Ticker
RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943248524
Phone
+1 650-624-1100
Business address
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
Former names
RIGEL PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-02 Dummer Wolfgang EVP & CMO Sale −5,389 $1.66 $9K 72,459
2023-01-26 Dummer Wolfgang EVP & CMO Grant or award · Employee Stock Option (right to buy) +50,000 100,000
2022-12-28 Dummer Wolfgang EVP & CMO Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2022-01-24 Dummer Wolfgang EVP & CMO Grant or award +50,000 67,848
2022-01-24 Dummer Wolfgang EVP & CMO Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-11-04 Dummer Wolfgang EVP & CMO Grant or award · Stock Option (Right to Buy) +37,500 37,500
2021-01-27 Dummer Wolfgang EVP & CMO Grant or award · Stock Option(right to buy) +125,000 125,000
2021-01-27 Dummer Wolfgang EVP & CMO Grant or award · Stock Option (right to buy) +37,500 37,500
2019-11-18 Dummer Wolfgang EVP & CMO Grant or award · Employee Stock Option (right to buy) +220,000 220,000

Page 1 of 1 · 9 trades